Skip to main content
Argha Mario Mallick on Muck Rack

Argha Mario Mallick

As seen in: Royal Society of Chemistry, DEV Community
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Argha Mario

Contact Argha Mario, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Google Skills Arcade Facilitator Program 2026: Why Every Google Cloud Learner Should Join

|
By Argha Mario Mallick
| DEV Community
Every year, thousands of developers, students, and cloud enthusiasts join Google Skills Arcade to gain practical experience with Google Cloud. The Google Skills Arcade Facilitator Program 2026 takes that experience even further. It's completely free, offers structured learning paths across modern cloud technologies, and rewards participants with Arcade Points and Bonus Points that contribute toward Google Skills Arcade prize tiers.
Open in Who Shared Issue with article?

Designed Gramicidin Inspired Stabilized Peptide-based Therapeutics to Potentiate Immunotherapy Against Aggressive Kidney Cancer

|
By Rituparna Roy, Argha Mario Mallick, Ananya Chatterjee, Arun Bahadur Gurung
| Royal Society of Chemistry Verified
Designed Gramicidin Inspired Stabilized Peptide-based Therapeutics to Potentiate Immunotherapy Against Aggressive Kidney Cancer This study reports engineered protease-stable, gramicidin-inspired, peptide-based proton transporter LD8∆, having alternate L- and D- amino acid residues to treat highly chemoresistant, radioresistant, immunosuppressive metastatic renal cell carcinomas (RCCs) cell line SK-RC-45.
Open in Who Shared Issue with article?

Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer

|
By Argha Mario Mallick, Abhijit Biswas, Sukumar Mishra, Sonali Jadhav
| Royal Society of Chemistry Verified
Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer† Argha Mario Mallick, a Abhijit Biswas,‡b Sukumar Mishra,‡a Sonali Jadhav,c Kasturee Chakraborty, a Archana Tripathi,a Arnab Mukherjee *c and Rituparna Sinha Roy *ade Abstract RNA interference based therapeutic gene silencing is an emerging platform for managing highly metastatic breast cancer.
Open in Who Shared Issue with article?
See all 3 articles